Literature DB >> 11115786

All-trans-retinoic acid and polyriboinosinoic:polyribocytidylic acid cooperate to elevate anti-tetanus immunoglobulin G and immunoglobulin M responses in vitamin A-deficient lewis rats and Balb/c mice.

K L DeCicco1, A C Ross.   

Abstract

Vitamin A (VA) deficiency compromises antibody responses to T-cell-dependent antigens such as tetanus toxoid, but this effect can be reversed through administration of retinol or retinoic acid (RA). To test whether RA and polyriboinosinioc : polyribocytidylic acid (PIC), a known inducer of several forms of interferon (IFN), can cooperate to increase specific immunoglobulin (Ig)G and IgM production during VA deficiency, rats and mice were made VA-deficient, immunized with TT and treated with all-trans-RA, PIC or their combination. VA-deficient rats produced low primary and secondary anti-tetanus IgG responses (VA-deficient controls v. VA-sufficient controls P < 0.001), although total IgG was slightly elevated when compared with VA-sufficient control rats. Although RA administered alone elevated antibody production during VA deficiency to control levels, RA combined with PIC synergistically enhanced these responses (RA and PIC group v. all other groups P < 0.0001). In contrast, Balb/c mice maintained on a VA-deficient diet and immunized in a similar fashion showed no impairment in antigen-specific IgG levels, but treatment with a combination of RA and PIC still evoked an additive enhancement in antigen-specific antibody production. Additionally, RA and PIC administration to VA-sufficient mice resulted in elevated antibody responses, suggesting that this combination should be evaluated further for its immuno-stimulatory effects.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115786     DOI: 10.1017/s0029665100000756

Source DB:  PubMed          Journal:  Proc Nutr Soc        ISSN: 0029-6651            Impact factor:   6.297


  7 in total

1.  The anti-tetanus immune response of neonatal mice is augmented by retinoic acid combined with polyriboinosinic:polyribocytidylic acid.

Authors:  Yifan Ma; A Catharine Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

2.  All-trans-retinoic acid and polyriboinosinic : polyribocytidylic acid in combination potentiate specific antibody production and cell-mediated immunity.

Authors:  K L DeCicco; J D Youngdahl; A C Ross
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

Review 3.  Vitamin A and retinoic acid in the regulation of B-cell development and antibody production.

Authors:  A Catharine Ross; Qiuyan Chen; Yifan Ma
Journal:  Vitam Horm       Date:  2011       Impact factor: 3.421

Review 4.  Potential for use of retinoic acid as an oral vaccine adjuvant.

Authors:  Mpala Mwanza-Lisulo; Paul Kelly
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-19       Impact factor: 6.237

5.  Retinoic acid and polyriboinosinic:polyribocytidylic acid stimulate robust anti-tetanus antibody production while differentially regulating type 1/type 2 cytokines and lymphocyte populations.

Authors:  Yifan Ma; Qiuyan Chen; A Catharine Ross
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

Review 6.  Augmentation of antibody responses by retinoic acid and costimulatory molecules.

Authors:  A Catharine Ross; Qiuyan Chen; Yifan Ma
Journal:  Semin Immunol       Date:  2008-09-25       Impact factor: 11.130

7.  Toll-like receptor 3 ligand and retinoic acid enhance germinal center formation and increase the tetanus toxoid vaccine response.

Authors:  Yifan Ma; A Catharine Ross
Journal:  Clin Vaccine Immunol       Date:  2009-08-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.